Evidence map›Paper›PMID 28243116›Full record

ArticleOncoTargets and therapy2017

Effects of

Hai-Yong Chen, Yao-Min Chen, Jian Wu, Fu-Chun Yang, Zhen Lv, Yi-Gang Qian, Shu-Sen Zheng

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Hai-Yong ChenDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases.
Yao-Min ChenDepartment of Breast Surgery, The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
Jian WuDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases.
Fu-Chun YangDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases.
Zhen LvDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases.
Yi-Gang QianDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases.
Shu-Sen ZhengDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases.
Second Military Medical University · CNCenter for Innovation · USFirst Affiliated Hospital Zhejiang University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the correlations of two hepatocyte growth factor (

methodsFrom March 2011 to June 2012, 109 PLC patients (the case group) who chose TACE as primary treatment and 80 healthy people (the control group) who had undergone physical examination in The First Affiliated Hospital, Zhejiang University were selected during the same period. Gene polymorphisms of

resultsThere were significant differences in genotype and allele frequencies of

conclusionOur results indicated that

Indexed as

gene polymorphismshepatocyte growth factorHGFprimary liver cancerrs2074725rs5745652TACE efficacytranshepatic arterial chemotherapeutic embolism efficacy

Identifiers

PMID28243116
PMCPMC5315352
OpenAlexW2588588514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.